Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice

References

• Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960–7.
   PubMed Web of Science ®Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387–95.
   PubMed Web of Science ®Google Scholar
• Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829–38.
   PubMed Web of Science ®Google Scholar
• Shimano HN, Yahagi M, Amemiya-Kudo AH, Hasty J, Osuga Y, Tamura F, Sterol regulatory element binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999;274:35832–9.
   PubMed Web of Science ®Google Scholar
• Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 2002;277:9520–8.
   PubMed Web of Science ®Google Scholar
• Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993;75:187–97.
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997;89:331–40.
   PubMed Web of Science ®Google Scholar
• Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997;5:846–54.
   Google Scholar
• Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 1998;273:35299–306.
   PubMed Web of Science ®Google Scholar
• Dobrzyn P, Dobrzyn A, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci USA 2004;17:6409–14.
   Google Scholar
• Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM, Hoffman EP, Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2005;4:251–61.
   Google Scholar
• Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 2002;277:19353–7.
   PubMed Web of Science ®Google Scholar
• De Souza CT, Araújo EP, Prada PO, Saad MJ, Boschero AC, Velloso LA. Short-term inhibition of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression reverses diet-induced diabetes mellitus and hepatic steatosis in mice. Diabetologia 2005;48:1860–71.
   PubMed Web of Science ®Google Scholar
• Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Physiol Pharmacol 1959;37:911–17.
   Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
   PubMed Web of Science ®Google Scholar
• Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 2003;278:34268–76.
   PubMed Web of Science ®Google Scholar
• Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 2000;106:1221–8.
   PubMed Web of Science ®Google Scholar
• Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterol 1994;107:1103–9.
   PubMed Web of Science ®Google Scholar
• Rebrin KG, Steil M, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995;44:1038–45.
   PubMed Web of Science ®Google Scholar
• Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345–53.
   PubMed Web of Science ®Google Scholar
• Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109:1125–31.
   PubMed Web of Science ®Google Scholar
• Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001;21:89–104.
   PubMed Web of Science ®Google Scholar
• Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002;99:11482–6.
   PubMed Web of Science ®Google Scholar
• Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 2005;115:1030–8.
   PubMed Web of Science ®Google Scholar
• Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptorγ1 (PPARγ1) overexpression. J Biol Chem 2003;278:498–505.
   PubMed Web of Science ®Google Scholar
• Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 2003;111:737–47.
   PubMed Web of Science ®Google Scholar
• Seo E, Park EJ, Joe Y, Kang S, Kim MS, Hong SH, Overexpression of AMPKalpha1 ameliorates fatty liver in hyperlipidemic diabetic rats. Korean. J Physiol Pharmacol 2009;13:449–54.
   Google Scholar
• Bergeron R, Previs SF, Cline GW, Perret P, Russell 3rd RR, Young LH. Effect of 5-aminoimidazole- 4-carboxamide-1-beta-d ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 2001;50:1076–82.
   PubMed Web of Science ®Google Scholar
• Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006;3:403–16.
   PubMed Web of Science ®Google Scholar
• Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008;295:G833–42.
   PubMed Web of Science ®Google Scholar
• Esfandiari F, You M, Villanueva JA, Wong DH, French SW, Halsted CH. S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet. Alcohol Clin Exp Res 2007;31:1231–9.
   PubMed Web of Science ®Google Scholar
• Rahman SM, Qadri I, Janssen RC, Friedman JE. Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J Lipid Res 2009;50:2193–202.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439–51.
   PubMed Web of Science ®Google Scholar
• Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91–100.
   PubMed Web of Science ®Google Scholar
• Cintra DE, Pauli JR, Araújo EP, Moraes JC, De Souza CT, Milanski M, Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 2008;48:628–37.
   PubMed Web of Science ®Google Scholar
• Ropelle ER, Pauli JR, Prada P, Cintra DE, Rocha GZ, Moraes JC, Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats. J Physiol 2009;587:2341–51.
   Google Scholar